Ad is loading...
MENU
RLAY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Relay Therapeutics (RLAY) Earnings Date & Reports

A.I. Advisor
published Earnings

RLAY is expected to report earnings to rise 19.02% to -74 cents per share on February 20

Relay Therapeutics RLAY Stock Earnings Reports
Q4'24
Est.
$-0.75
Q3'24
Beat
by $0.14
Q2'24
Beat
by $0.04
Q1'24
Beat
by $0.12
Q4'23
Beat
by $0.05
The last earnings report on November 06 showed earnings per share of -62 cents, beating the estimate of -76 cents. With 1.93M shares outstanding, the current market capitalization sits at 854.49M.
View a ticker or compare two or three
RLAY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage precision medicines company, which focuses on using innovative experimental and computational approaches on protein motion for making medicines against intractable precision medicine targets

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
399 Binney Street
Phone
+1 617 370-8837
Employees
323
Web
https://www.relaytx.com